AGENUS INC Deferred Tax Assets, Operating Loss Carryforwards
AGENUS INC (AGEN) had Deferred Tax Assets, Operating Loss Carryforwards of $192.22 million as of 2014-12-31, per its 10-K filed 2015-03-16.
Discontinued › Notes › Income Taxes › Deferred Tax Assets, Net
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2015-03-16
- 2014-12-31: Deferred Tax Assets, Operating Loss Carryforwards $192.22M.
- 2013-12-31: Deferred Tax Assets, Operating Loss Carryforwards $177.59M.
- 2012-12-31: Deferred Tax Assets, Operating Loss Carryforwards $178.97M.
- 2011-12-31: Deferred Tax Assets, Operating Loss Carryforwards $175.97M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2014-12-31 | $192.22M 10-K · filed 2015-03-16 |
| 2013-12-31 | $177.59M 10-K · filed 2015-03-16 |
| 2012-12-31 | $178.97M 10-K · filed 2014-03-07 |
| 2011-12-31 | $175.97M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |